Stock listing
Canbridge Pharmaceuticals Inc.
Selected listing: MF1 · FWB · EUR · DE
Canbridge Pharmaceuticals Inc. (Frankfurt:MF1), Health Technology. Latest release Aug 18, 2026: CANbridge Announces NHIA Reimbursement Approval of Livmarli…
- Ticker
- Frankfurt:MF1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Canbridge Pharmaceuticals Inc.
CANbridge Announces NHIA Reimbursement Approval of Livmarli for Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis in Taiwan
August 18, 2026
CANbridge Announces Strategic Partnership and Investment from Baheal to Strengthen Commercialization of Rare Disease Products
August 14, 2025
CANbridge Pharmaceuticals Successfully Obtains Drug Manufacturing License Type B Certificate
October 29, 2024
CANbridge Reports Positive Topline Data from CAN103 Pivotal Trial for Gaucher Disease in China, Plans NDA Filing in Q4 2024
August 19, 2024
CANbridge Announces NDA Acceptance of CAN108 for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis by China's National Medical Products Administration
October 18, 2023
Research Canbridge Pharmaceuticals Inc.
Canbridge Pharmaceuticals Inc. company profile
View the public company page for Canbridge Pharmaceuticals Inc. on 6ix.
Canbridge Pharmaceuticals Inc. news
Read company news and market updates connected to Canbridge Pharmaceuticals Inc..
Canbridge Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Canbridge Pharmaceuticals Inc..
Alternate listings
1228:HKEX
HK · HKD
Alternate listing for Canbridge Pharmaceuticals Inc.; the primary context on this page is MF1:FWB.
A3DGDS:LSX
DE · EUR
Alternate listing for Canbridge Pharmaceuticals Inc.; the primary context on this page is MF1:FWB.
A3DGDS:LS
DE · EUR
Alternate listing for Canbridge Pharmaceuticals Inc.; the primary context on this page is MF1:FWB.
CNBRF:OTC
US · USD
Alternate listing for Canbridge Pharmaceuticals Inc.; the primary context on this page is MF1:FWB.